Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.verified

CLBS

Price:

$0.4264

Market Cap:

$3.35M

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences...[Read more]

Industry

Biotechnology

IPO Date

1995-11-03

Stock Exchange

NASDAQ

Ticker

CLBS

The PE Ratio as of July 2024 (TTM) for Caladrius Biosciences, Inc. (CLBS) is -1.08

According to Caladrius Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.08. This represents a change of -47.64% compared to the average of -2.07 of the last 4 quarters.

Caladrius Biosciences, Inc. (CLBS) Historical PE Ratio (quarterly & annually)

How has CLBS PE Ratio performed in the past?

The mean historical PE Ratio of Caladrius Biosciences, Inc. over the last ten years is -0.96. The current -1.08 PE Ratio has changed 11.21% with respect to the historical average. Over the past ten years (40 quarters), CLBS's PE Ratio was at its highest in in the June 2020 quarter at 0.89. The PE Ratio was at its lowest in in the June 2017 quarter at -5.13.

Quarterly (TTM)
Annual

Average

-0.96

Median

-0.51

Minimum

-2.71

Maximum

-0.06

Caladrius Biosciences, Inc. (CLBS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Caladrius Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 760.29%

Maximum Annual PE Ratio = -0.06

Minimum Annual Increase = -82.56%

Minimum Annual PE Ratio = -2.71

Quarterly (TTM)
Annual
YearPE RatioChange
2021-0.47-82.56%
2020-2.71102.61%
2019-1.34-37.24%
2018-2.139.55%
2017-1.95249.92%
2016-0.56760.29%
2015-0.06-53.00%
2014-0.1413.77%
2013-0.1235.38%
2012-0.09144.87%

Caladrius Biosciences, Inc. (CLBS) Average PE Ratio

How has CLBS PE Ratio performed in the past?

The current PE Ratio of Caladrius Biosciences, Inc. (CLBS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.51

5-year avg

-1.72

10-year avg

-0.96

Caladrius Biosciences, Inc. (CLBS) PE Ratio vs. Peers

How is CLBS’s PE Ratio compared to its peers?

Caladrius Biosciences, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Caladrius Biosciences, Inc. (CLBS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caladrius Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caladrius Biosciences, Inc. (CLBS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caladrius Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Caladrius Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Caladrius Biosciences, Inc. (CLBS)?

What is the highest PE Ratio for Caladrius Biosciences, Inc. (CLBS)?

What is the 3-year average PE Ratio for Caladrius Biosciences, Inc. (CLBS)?

What is the 5-year average PE Ratio for Caladrius Biosciences, Inc. (CLBS)?

How does the current PE Ratio for Caladrius Biosciences, Inc. (CLBS) compare to its historical average?